drugset / Trial / NCT07038941
Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is testing CG2001, a new medicine that is applied as a light foam to the scalp and is being developed to treat male-pattern hair loss (androgenetic alopecia). The main goals are to find out: 1. Whether single and repeated daily doses of CG2001 are safe and well-tolerated 2. How much of the drug, if any, enters the bloodstream (pharmacokinetics)
Timeline
- Start
- 2024-03-19
- Primary completion
- 2024-06-02
- Completion
- 2024-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Finasteride | Small molecule | 0.025 % | Topical |
| Subject | Finasteride | Small molecule | 0.05 % | Topical |
| Subject | Finasteride | Small molecule | 0.075 % | Topical |
| Subject | Finasteride | Small molecule | 0.1 % | Topical |
| Subject | Minoxidil | Small molecule | 5 % | Topical |